CompletedNot Applicable

Myoglobin Removal by High Cut-off CVVHD

Germany16 participantsStarted 2011-11

Plain-language summary

A high cut-off dialyzer (septeX) is tested for the removal of myoglobin which is not efficiently removed by standard high flux dialysis membranes. Hypothesis: The high cut-off dialyzer (septeX) can remove 2-fold more efficiently myoglobin from the circulation of Rhabdomyolysis patients as by conventional treatment with standard high flux dialyzer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute Rhabdomyolysis * placed central venous catheter * Indication for RRT due to Serum CK level \> 5000 u/L * Age ≥ 18 years * Signed ICF Exclusion Criteria: * End stage CKD (dialysis dependent) renal failure before manifestation of rhabdomyolysis * Pregnancy or lactation * Palliative treatment * Participation in other clinical studies

What they're measuring

Myoglobin plasma level

Timeframe: 24h

Trial details

NCT IDNCT01467180

SponsorVantive Health LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-04

View on ClinicalTrials.gov More Rhabdomyolysis trials